The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the warrants (the “Warrants”) — ticker symbol HIPO.WS — to purchase common stock of Hippo Holdings Inc. (the “Company”) from the NYSE. Trading in the Company’s Warrants will be suspended immediately. Trading in the Company’s common stock — ticker symbol HIPO — will not be affected and will continue on the NYSE.

NYSE Regulation has determined that the Company’s Warrants are no longer suitable for listing based on “abnormally low selling price” levels, pursuant to Section 802.01D of the NYSE Listed Company Manual.

The Company has a right to a review of this determination by a Committee of the Board of Directors of the Exchange. The NYSE will apply to the Securities and Exchange Commission to delist the Company’s Warrants upon completion of all applicable procedures, including any appeal by the Company of the NYSE Regulation staff’s decision.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240909059970/en/